Subject:  The RAPID REPORT, Letter from Dr. Kenneth Olden (fwd)
Date:     Tue, 15 Jun 1999 153753 -0500 (CDT)
From:     "Roy L. Beavers" <rbeavers@llion.org>
To:       emfguru <rbeavers@llion.org>
--------------------------------------------------



---------- Forwarded message ----------


   DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health
   Service
   
  
   
   National Institutes of Health
   National Institute of
   Environmental Health Sciences
   P. O. Box 12233
   Research Triangle Park, NC 27709
   
   May 4, 1999
   
   Dear Reader:
   
   In 1992, the U.S. Congress authorized the Electric and Magnetic Fields
   Research and Public Information Dissemination Program (EMF-RAPID
   Program) in the Energy Policy Act. The Congress instructed the
   National Institute of Environmental Health Sciences (NIEHS), National
   Institutes of Health and the U.S. Department of Energy (DOE) to direct
   and manage a program of research and analysis aimed at providing
   scientific evidence to clarify the potential for health risks from
   exposure to extremely low frequency electric and magnetic fields
   (ELF-EMF). The EMF-RAPID Program had three basic components: 1) a
   research program focusing on health effects research, 2) information
   compilation and public outreach and 3) a health assessment for
   evaluation of any potential hazards arising from exposure to ELF-EMF.
   The NIEHS was directed to oversee the health effects research and
   evaluation, and the DOE was given the responsibility for overall
   administration of funding and engineering research aimed at
   characterizing and mitigating these fields. The Director of the NIEHS
   was mandated upon completion of the Program to provide this report
   outlining the possible human health risks associated with exposure to
   ELF-EMF. The scientific evidence used in preparation of this report
   has undergone extensive scientific and public review. The entire
   process was open and transparent. Anyone who wanted "to have a say"
   was provided the opportunity.
   
   The scientific evidence suggesting that ELF-EMF exposures pose any
   health risk is weak. The strongest evidence for health effects comes
   from associations observed in human populations with two forms of
   cancer: childhood leukemia and chronic lymphocytic leukemia in
   occupationally exposed adults. While the support from individual
   studies is weak, the epidemiological studies demonstrate, for some
   methods of measuring exposure, a fairly consistent pattern of a small,
   increased risk with increasing exposure that is somewhat weaker for
   chronic lymphocytic leukemia than for childhood leukemia. In contrast,
   the mechanistic studies and the animal toxicology literature fail to
   demonstrate any consistent pattern across studies although sporadic
   findings of biological effects have been reported. No indication of
   increased leukemias in experimental animals has been observed.
   
   The lack of connection between the human data and the experimental
   data (animal and mechanistic) severely complicates the interpretation
   of these results. The human data are in the "right" species, are tied
   to "real life" exposures and show some consistency that is difficult
   to ignore. This assessment is tempered by the observation that given
   the weak magnitude of these increased risks, some other factor or
   common source of error could explain these findings. However, no
   consistent explanation other than exposure to ELF-EMF has been
   identified.
   
   Epidemiological studies have serious limitations in their ability to
   demonstrate a cause and effect relationship whereas laboratory
   studies, by design, can clearly show that cause and effect are
   possible. Virtually all of the laboratory evidence in animals and
   humans and most of the mechanistic work done in cells fail to support
   a causal relationship between exposure to ELF-EMF at environmental
   levels and changes in biological function or disease status. The lack
   of consistent, positive findings in animal or mechanistic studies
   weakens the belief that this association is actually due to ELF-EMF,
   but it cannot completely discount the epidemiological findings.
   
   The NIEHS concludes that ELF-EMF exposure cannot be recognized at this
   time as entirely safe because of weak scientific evidence that
   exposure may pose a leukemia hazard. In my opinion, the conclusion of
   this report is insufficient to warrant aggressive regulatory concern.
   However, because virtually everyone in the United States uses
   electricity and therefore is routinely exposed to ELF-EMF, passive
   regulatory action is warranted such as a continued emphasis on
   educating both the public and the regulated community on means aimed
   at reducing exposures. The NIEHS does not believe that other cancers
   or non-cancer health outcomes provide sufficient evidence of a risk to
   currently warrant concern.
   
   The interaction of humans with ELF-EMF is complicated and will
   undoubtedly continue to be an area of public concern. The EMF-RAPID
   Program successfully contributed to the scientific knowledge on
   ELF-EMF through its support of high quality, hypothesis-based
   research. While some questions were answered, others remain. Building
   upon the knowledge base developed under the EMF-RAPID Program,
   meritorious research on ELF-EMF through carefully designed,
   hypothesis-driven studies should continue for areas warranting
   fundamental study including leukemia. Recent research in two areas,
   neurodegenerative diseases and cardiac diseases associated with heart
   rate variability, have identified some interesting and novel findings
   for which further study is ongoing.
   
   Advocacy groups have opposing views concerning the health effects of
   ELF-EMF. Some advocacy groups want complete exoneration and others
   want a more serious indictment. Our conclusions are prudent and
   consistent with the scientific data. I am satisfied with the report
   and believe it provides a pragmatic, scientifically-driven basis for
   any further regulatory review.
   
   I am pleased to transmit this report to the U.S. Congress.
   

   
   Sincerely,
   
   Kenneth Olden, Ph.D.
   Director
   



Archive provided courtesy of WaveGuide, http://www.wave-guide.org
Reprinted with permission of Roy Beavers, http://www.feb.se/EMF-L/EMF-L.html